{"schema_version":"secwatch.filing_event.v1","accession":"0001062993-24-001181","form_type":"8-K","ticker":null,"cik":"0001617765","company_name":"EVOME MEDICAL TECHNOLOGIES INC.","filed_at":"2024-01-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.826772+00:00","generated_at":"2026-06-06T20:03:41.230643+00:00","sec_items":["5.02","5.03","7.01","8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Evome Medical (fka Salona Global) changes name, reports Q3 revenue up 18.5% QoQ and positive Adj. EBITDA","bullets":["Company renamed Evome Medical Technologies Inc., ticker EVMT effective Jan 22, 2024.","Director Leslie Cross resigned effective Jan 17, 2024; no disagreement disclosed.","Q3 FY2023 (Sep 30): revenue +18.5% QoQ, gross profit +29% QoQ, positive Adj. EBITDA of $749,425.","Reduced Biodex acquisition debt by $428,237 in Q3; balance extended to July 2025.","Plans to launch two new Biodex products (SpaceTek Knee, Reactive Step Trainer) into private PT market."],"urls":{"canonical":"https://secwatch.observer/filing/0001062993-24-001181","json":"https://secwatch.observer/filing/0001062993-24-001181.json","markdown":"https://secwatch.observer/filing/0001062993-24-001181.md","text":"https://secwatch.observer/filing/0001062993-24-001181.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1617765/000106299324001181/0001062993-24-001181-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1617765/000106299324001181/form8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T20:03:41.230643+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"fe1bdd3fbb","claim":"Leslie Cross resigned as Director at EVOME MEDICAL TECHNOLOGIES INC..","evidence_excerpt":"On January 17, 2024, Leslie Cross notified the Board of Directors of Salona Global Medical Device Corporation (the \"Company\") of his intention to resign from the Company's Board of Directors effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1617765/000106299324001181/0001062993-24-001181-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"917d960418099440668a1ca6e0b8ac1d3930ed69","claim":"EVOME MEDICAL TECHNOLOGIES INC.: Articles amended to reflect corporate name change to Evome Medical Technologies Inc (effective 2024-01-22).","evidence_excerpt":"the Board of Directors amended the Company's Articles to reflect the corporate name Evome Medical Technologies Inc.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1617765/000106299324001181/0001062993-24-001181-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2024-01-22"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}